Even though noteworthy advancements have been made in the treatment of esophageal tumor, this destructive malignancy normally presents as locally but highly developed disease with a poor diagnosis. In spite of improvements in the recognition of pre-malignant pathology, modern preventive strategies, and the development of efficient combination of therapies, the in general occurrence of esophageal cancer has risen. A clear association has been recognized between the expansion of esophageal cancer and Helicobacter pylori disease, gastroesophageal reflux infection, , and intense use.

Esophageal cancer

is the of the esophagus and is more frequent among men over 50 years of age than women. It accounts for just about 1% of all cancers in the North American population; esophageal cancer is the second most ordinary cancer in parts of Asia.  There are two major kinds of esophageal cancer.

  • Squamous Cell:

    squamous cell carcinoma is the most frequently diagnosed esophageal cancer around the world. This kind of cancer is typically found in the upper area of the esophagus.

  • Adenocarcinoma:

    This kind is frequently found in the lower part of the esophagus, close to the stomach.

Two problems associated with this cancer are:

Difficulty in swallowing:

One of the most palpable problems linked with this kind of tumor is difficulty in swallowing food. As the lump gets bigger, swallowing firm food becomes unattainable and ultimately only fluids can get by. After operation where part of the esophagus is detached, swallowing may be tough for time being but improve as healing progresses.

Weight loss

: A second problem that arises is weight loss because of the problems related with swallowing. Consulting a doctor in order to maintain a good dietetic condition is a significant step in treating esophageal cancer. Poor nourishment can slow down the healing process.

Treatment of esophageal cancer will depend on the phase of cancer at the time of analysis, the general health condition of the patient, and whether the tumor has multiplied to other organs. If the cancer is diagnosed in its most primitive stage, the patient’s probability of living is of five years after proper treatment. Unluckily, the majority of the cases of esophageal cancer are only revealed when the patient comes to their doctor because of swallowing intricacy, which doesn’t take place until advanced stages of the cancer growth.

Researchers are studying the method of using aspirin and antacids to put off esophageal adenocarcinoma in patients suffering from Barrett’s esophagus. Doctors are studying combinations of diverse drugs and various studies are on the go to come across innovative drugs that are efficient for esophageal tumor. Clinical trials are in progress to discover superior ways of reducing symptoms and side effects of present esophageal tumor treatments so as to perk up patients’ comfort and quality of life.